BioNTech SE (NASDAQ:BNTX) is included among the 10 Best Global Stocks to Buy According to Wall Street Analysts. BioNTech SE ...
Here are three reasons why I prefer AbbVie stock right now. Once a pharmaceutical company is granted a patent for a new drug ...
Add Yahoo as a preferred source to see more of our stories on Google. Pfizer Inc. signage is seen on July 22, 2020 in New York City. (Jeenah Moon via Getty Images) This story was originally published ...
LONDON, April 1 (Reuters) - Vaccine makers Pfizer and BioNTech halted a large U.S. trial of their updated COVID-19 vaccine in healthy adults aged 50 to 64, saying enrollment in the trials had been too ...
Pfizer and BioNTech have halted a U.S. study of their updated COVID-19 vaccine in adults ages 50-64 due to slow enrollment, a Pfizer spokesperson confirmed to Becker’s. “We can confirm our ...
BioNTech SE (Nasdaq: BNTX, "BioNTech" or "the Company") will announce its financial results for the first quarter 2026 on Tuesday, May 5, 2026. Additionally ...
The report contained information indicating that the COVID-19 vaccine cut hospital visits nearly in half for vaccinated ...
Pfizer's Chief Strategy and Innovation Officer, Andrew Baum, is transitioning to a new role and will eventually leave the ...
A great puzzle for Stalin was why the British threw Winston Churchill out of office in 1945. The last meeting of the “Big ...
Cyprus Mail on MSN
Pfizer, BioNTech halt US COVID vaccine study after recruitment struggles
Vaccine makers Pfizer PFE.N and BioNTech 22UAy.DE halted a large U.S. trial of their updated COVID-19 vaccine in healthy adults aged 50 to 64, saying enrollment in the trials had been too low to ...
About 90 percent of people fully inoculated by the Pfizer-BioNTech vaccine are well protected from variants of the novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results